Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of Intravitreal Ranibizumab Injection With Retinal Vein Occlusion (RVO)

This study is enrolling participants by invitation only.
Sponsor:
Information provided by:
Novartis Korea Ltd.
ClinicalTrials.gov Identifier:
NCT00942864
First received: July 17, 2009
Last updated: July 21, 2009
Last verified: July 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)